The association between cytokine gene polymorphisms and the outcomes of chronic HBV infection

被引:21
作者
Li, Chen
Zhi-Xin, Chen
Li-Juan, Zhang
Chen, Pan
Xiao-Zhong, Wang [1 ]
机构
[1] Fujian Med Univ, Union Hosp, Dept Gastroenterol, Fuzhou, Peoples R China
[2] Fuzhou Infect Dis Hosp, Fuzhou, Peoples R China
关键词
tumor necrosis factor-alpha; interleukin-10; interleukin-6; gene polymorphisms; hepatitis B virus;
D O I
10.1016/j.hepres.2006.07.007
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective: To investigate whether the polymorphisms in TNF-alpha gene, IL-10 gene and IL-6 gene were associated with the outcomes of chronic HBV infection. Methods: The genotypes at the position -238 and -308 of TNF-alpha gene, -1082, -819 and -592 of IL-10 gene, - 174 of IL-6 gene in the promoter region were detected in 62 chronic hepatitis B patients, 60 asymptomatic carriers and 63 heath controls by polymerase chain reaction-sequence specific primer assay. Results: The frequency of G/G genotype at the position - 238 in the promoter region of TNF-alpha gene increased significantly in hepatitis B patients, in comparison with that in controls (83.9% versus 66.7%, P < 0.05), whereas the frequency of G/A genotype at the same position decreased significantly in hepatitis B patients comparing with that in controls (16.1% versus 33.3%, P < 0.05). Between chronic hepatitis B patients, asymptomatic carriers and heath controls, the genotypes frequency at the position -308 of TNF-alpha gene, - 1082, - 819 and -592 of IL-10 gene, -174 of IL-6 gene in the promoter region showed no significant differences (P > 0.05). Conclusions: The presence of G/A genotype at the position - 238 may contribute to virus elimination, whereas the presence of G/G genotype at the position -238 may lead to virus persistent infection. There were no association between IL-10 gene and IL-6 gene polymorphisms and chronic HBV infection. (C) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:158 / 166
页数:9
相关论文
共 45 条
[1]   Interleukin-10 therapy - Review of a new approach [J].
Asadullah, K ;
Sterry, W ;
Volk, HD .
PHARMACOLOGICAL REVIEWS, 2003, 55 (02) :241-269
[2]   Polymorphisms in tumour necrosis factor-α, transforming growth factor-β, interleukin-10, interleukin-6, interferon-γ, and outcome of hepatitis C virus infection [J].
Barrett, S ;
Collins, M ;
Kenny, C ;
Ryan, E ;
Keane, CO ;
Crowe, J .
JOURNAL OF MEDICAL VIROLOGY, 2003, 71 (02) :212-218
[3]  
Ben-Ari Z, 2003, AM J GASTROENTEROL, V98, P144, DOI 10.1111/j.1572-0241.2003.07179.x
[4]  
China medical association infectious diseases and parasitic diseases branch Society of Hepatology, 2000, Chinese J Hepatol, V8, P324
[5]   Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus [J].
Chong, WP ;
Ip, WK ;
Lau, CS ;
Chan, TM ;
Lau, YL .
GENES AND IMMUNITY, 2004, 5 (06) :484-492
[6]   Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C [J].
Chu, CJ ;
Hussain, M ;
Lok, ASF .
GASTROENTEROLOGY, 2002, 122 (07) :1756-1762
[7]   Interleukin-1, interleukin-10 and tumour necrosis factor-alpha gene polymorphisms in hepatitis C virus infection: an investigation of the relationships with spontaneous viral clearance and response to alpha-interferon therapy [J].
Constantini, PK ;
Wawrzynowicz-Syczewska, M ;
Clare, M ;
Boron-Kaczmarska, A ;
McFarlane, IG ;
Cramp, ME ;
Donaldson, PT .
LIVER, 2002, 22 (05) :404-412
[8]   Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa [J].
Edwards-Smith, CJ ;
Jonsson, JR ;
Purdie, DM ;
Bansal, A ;
Shorthouse, C ;
Powell, EE .
HEPATOLOGY, 1999, 30 (02) :526-530
[9]   The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis [J].
Fishman, D ;
Faulds, G ;
Jeffery, R ;
Mohamed-Ali, V ;
Yudkin, JS ;
Humphries, S ;
Woo, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (07) :1369-1376
[10]   The role of interleukin-10 promoter polymorphisms in the clinical expression of primary Sjogren's syndrome [J].
Font, J ;
García-Carrasco, M ;
Ramos-Casals, M ;
Aldea, AI ;
Cervera, R ;
Ingelmo, M ;
Vives, J ;
Yagüe, J .
RHEUMATOLOGY, 2002, 41 (09) :1025-1030